Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, Herlev, Denmark.
Am J Respir Crit Care Med. 2010 May 15;181(10):1085-92. doi: 10.1164/rccm.200912-1951OC. Epub 2010 Feb 18.
Idiopathic interstitial pneumonia is characterized by pulmonary fibrosis and high mortality.
We examined the association between ever-diagnosed venous thromboembolism and risk of incident idiopathic interstitial pneumonia. Venous thromboembolism was taken as a proxy for a procoagulant state in an individual.
We conducted a study of the entire Danish population from 1980 through 2007, comprising 7.4 million individuals. Incident idiopathic interstitial pneumonia, ever-diagnosed venous thromboembolism, and use of prescription anticoagulants were drawn from national Danish registries.
Age-standardized incidence rates per 10,000 person-years for idiopathic interstitial pneumonia were higher among those ever diagnosed with venous thromboembolism (1.8; n = 158,676), pulmonary embolism (2.8; n = 70,586), and deep venous thrombosis only (1.2; n = 88,090), than among control subjects (0.8; n = 7,260,278). Multivariate-adjusted hazard ratios for idiopathic interstitial pneumonia were 1.8 (95% confidence interval [CI], 1.7-1.9) in those ever diagnosed with venous thromboembolism, 2.4 (95% CI, 2.3-2.6) in those ever diagnosed with pulmonary embolism, and 1.3 (95% CI, 1.2-1.4) in those ever diagnosed with deep venous thrombosis only, compared with control subjects. Corresponding hazard ratios in those ever diagnosed with venous thromboembolism stratified in those ever and never treated with anticoagulants were 1.4 (95% CI, 1.2-1.6) and 2.8 (95% CI, 2.4-3.1) (venous thromboembolism x anticoagulation use interaction on idiopathic interstitial pneumonia outcome: P = 1.5 x 10(-10)).
In the general population, ever-diagnosed venous thromboembolism was associated with idiopathic interstitial pneumonia, particularly among those never treated with anticoagulants.
特发性间质性肺炎的特征是肺纤维化和高死亡率。
我们研究了曾确诊的静脉血栓栓塞与特发性间质性肺炎发病风险之间的关系。静脉血栓栓塞被视为个体促凝状态的标志物。
我们对 1980 年至 2007 年期间的整个丹麦人群进行了一项研究,该人群包括 740 万人。特发性间质性肺炎、曾确诊的静脉血栓栓塞以及处方抗凝剂的使用情况均来自丹麦国家登记处。
特发性间质性肺炎的年龄标准化发病率,在曾确诊过静脉血栓栓塞(1.8;n=158676)、肺栓塞(2.8;n=70586)和单纯深静脉血栓形成(1.2;n=88090)的患者中,高于对照组(0.8;n=7260278)。多变量调整的特发性间质性肺炎风险比为,曾确诊静脉血栓栓塞患者为 1.8(95%置信区间[CI],1.7-1.9),曾确诊肺栓塞患者为 2.4(95% CI,2.3-2.6),仅曾确诊深静脉血栓形成患者为 1.3(95% CI,1.2-1.4),与对照组相比。在曾确诊静脉血栓栓塞的患者中,根据是否曾接受抗凝治疗进行分层,特发性间质性肺炎的风险比分别为 1.4(95% CI,1.2-1.6)和 2.8(95% CI,2.4-3.1)(静脉血栓栓塞 x 抗凝使用对特发性间质性肺炎结局的交互作用:P=1.5×10(-10))。
在普通人群中,曾确诊的静脉血栓栓塞与特发性间质性肺炎相关,尤其是在从未接受抗凝治疗的患者中。